12-50085517-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BS1_SupportingBS2
The ENST00000394963.9(SMARCD1):āc.148C>Gā(p.Arg50Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000566 in 1,236,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 30)
Exomes š: 0.0000018 ( 0 hom. )
Consequence
SMARCD1
ENST00000394963.9 missense
ENST00000394963.9 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 4.63
Genes affected
SMARCD1 (HGNC:11106): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins, whose members display helicase and ATPase activities and which are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI and has sequence similarity to the yeast Swp73 protein. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SMARCD1. . Gene score misZ 3.4416 (greater than the threshold 3.09). Trascript score misZ 3.2646 (greater than threshold 3.09). GenCC has associacion of gene with Coffin-Siris syndrome 11, autism, susceptibility to, 15, Coffin-Siris syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.38416055).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000033 (5/151596) while in subpopulation AMR AF= 0.000328 (5/15250). AF 95% confidence interval is 0.000129. There are 0 homozygotes in gnomad4. There are 2 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCD1 | NM_003076.5 | c.148C>G | p.Arg50Gly | missense_variant | 1/13 | ENST00000394963.9 | NP_003067.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCD1 | ENST00000394963.9 | c.148C>G | p.Arg50Gly | missense_variant | 1/13 | 1 | NM_003076.5 | ENSP00000378414 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151596Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
5
AN:
151596
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000184 AC: 2AN: 1085164Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 513072
GnomAD4 exome
AF:
AC:
2
AN:
1085164
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
513072
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151596Hom.: 0 Cov.: 30 AF XY: 0.0000270 AC XY: 2AN XY: 74002
GnomAD4 genome
AF:
AC:
5
AN:
151596
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
74002
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2020 | The alteration results in an amino acid change:_x000D_ _x000D_ The c.148C>G (p.R50G) alteration is located in coding exon 1 of the SMARCD1 gene. This alteration results from a C to G substitution at nucleotide position 148, causing the arginine (R) at amino acid position 50 to be replaced by a glycine (G). The alteration is rare in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the c.148C>G alteration was observed in 0.0032% (1/31020) of total alleles studied. The altered amino acid is conserved throughout evolution:_x000D_ _x000D_ The p.R50 amino acid is conserved in available vertebrate species. The alteration is predicted tolerated by in silico modeling:_x000D_ _x000D_ The p.R50G alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N
REVEL
Uncertain
Sift
Benign
D;D;D;D
Sift4G
Benign
T;T;T;T
Polyphen
P;B;.;.
Vest4
MutPred
Loss of methylation at R50 (P = 0.0159);Loss of methylation at R50 (P = 0.0159);Loss of methylation at R50 (P = 0.0159);Loss of methylation at R50 (P = 0.0159);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at